Article
Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden.
Neurosurgery - 15 Oct 2020
Patel Kunal S, Everson Richard G, Yao Jingwen, Raymond Catalina, Goldman Jodi, Schlossman Jacob, Tsung Joseph, Tan Caleb, Pope Whitney B, Ji Matthew S, Nguyen Nhung T, Lai Albert, Nghiemphu Phioanh L, Liau Linda M, Cloughesy Timothy F, Ellingson Benjamin M
Abstract excerpt
BACKGROUND: Diffusion magnetic resonance (MR) characteristics are a predictive imaging biomarker for survival benefit in recurrent glioblastoma treated with anti-vascular endothelial growth factor (VEGF) therapy; however, its use in large volume recurrence has not been evaluated. OBJECTIVE: To determine if diffusion MR characteristics can predict survival outcomes in patients with large volume recurrent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.